Skip to content
AP World History: Modern · Globalization

Pharmaceutical access

Pharmaceutical access appears in 4 reviewed AP World History: Modern questions and sits in Globalization. Below are worked examples showing exactly how the exam tests it, with the answer marked and every distractor explained.

The fight over whether patent-holding drug makers set the price of medicine, or whether the sick can afford it. The defining case is antiretroviral therapy for HIV and AIDS. It made the disease survivable in rich countries while staying far out of reach in sub-Saharan Africa, home to about two-thirds of infected people.

Why it matters

It exposes a fault line in globalization. The same trade system that moved goods and money across borders also spread strict patent rules. The mechanism was TRIPS, the World Trade Organization's intellectual property agreement in force from 1995. Joining the WTO meant granting drug patents for twenty years. India had not granted product patents on medicines, so Indian firms copied the drugs: in 2001 Cipla offered a year of triple therapy for about $350 a patient, against more than $10,000 from the patent holders. In November 2001 the Doha Declaration on TRIPS and Public Health confirmed that governments could override a patent in a health emergency. So a legal document written in one country set survival rates in another. Drug firms said patents pay for research. Activists said profit was picking who lived.

How the exam tests it

A public-health excerpt lays out the clash between patents and access. The stem asks what larger tension of the era it shows. Credit goes to the trade-off between patent rules that fund new drugs and fair access to life-saving treatment. Answers about aid budgets or hospital capacity are wrong.

Don’t confuse it with

Humanitarian aid is about how much donors choose to give; this fight was about patent law and pricing power.

Pharmaceutical access in real questions

Example 1Medium
"The HIV/AIDS pandemic, which has killed more than thirty-six million people since it was first identified in 1981, has been both a global health crisis and a test of international solidarity. In the wealthy nations of North America and Europe, antiretroviral drugs transformed AIDS from a death sentence into a manageable chronic condition. But in sub-Saharan Africa, where two-thirds of all HIV-infected people live, these life-saving drugs were priced beyond reach. Pharmaceutical companies claimed that patent protections were necessary to fund research. Activists countered that profits should not determine who lives and who dies." — Global health researcher, 2010 The conflict described in this passage between patent protections and access to medicines most directly reflects which of the following broader tensions in the era of globalization?
  1. AThe emergence of a universal global consensus that pharmaceutical firms should distribute all essential medicines free of charge regardless of their research and development costs
  2. BThe complete success of international organizations such as the WHO in guaranteeing fully equal access to advanced healthcare and medicines across both wealthy and developing nations
  3. CThe tension between intellectual property rights that incentivize innovation and the need for equitable access to life-saving technologiesCorrect
  4. DThe growing irrelevance of economic factors such as pricing and national wealth in shaping divergent health outcomes across different regions of the globalized world

Why C is right

The passage describes the clash between pharmaceutical companies defending patents as necessary for research funding and activists arguing for affordable access to life-saving drugs. This directly reflects the broader globalization-era tension between intellectual property regimes that incentivize innovation and the imperative for equitable access to essential technologies.
Why the other 3 choices miss
A
Incorrect because the passage describes a conflict between rival positions on drug pricing, not a universal consensus; pharmaceutical companies advocated for patent protections to fund research, not for distributing medicines free of charge.
B
Incorrect because the passage describes a failure rather than a success: antiretroviral drugs were accessible in wealthy nations but priced beyond reach in sub-Saharan Africa, contradicting any claim that international organizations ensured equal access.
D
Incorrect because the entire passage demonstrates that economic factors such as drug pricing and wealth disparities directly determined health outcomes, with people in wealthier nations surviving while those in poorer nations died.

Studied alongside

Other concepts from Globalization.